StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PLSE

Pulse Biosciences, Inc.

PLSE Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$37.73
+2.69 +7.68%

Key statistics

from XBRL data in SEC filings
Market cap
$2.61B
Revenue (TTM)
$751K
Net income (TTM)
-$74.6M
EPS (TTM)
$-1.10
P/E ratio
Dividend yield
Free cash flow
-$54.4M
Cash
$68.3M
Total assets
$81.6M
Gross margin
52-week range
$12.56 – $38.29

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 29, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Other events Jun 10, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events May 6, 2026 8-K Results of operations (earnings release); Other events May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Regulation FD disclosure Apr 27, 2026 8-K Regulation FD disclosure Apr 16, 2026 8-K Director or officer change; Regulation FD disclosure Apr 9, 2026 8-K Other events Apr 7, 2026 8-K Director or officer change Mar 27, 2026 8-K Other events Mar 17, 2026 8-K Other events Mar 12, 2026 8-K Other events Mar 9, 2026 8-K Regulation FD disclosure Mar 3, 2026 8-K/A Director or officer change Mar 2, 2026 8-K Director or officer change Feb 27, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Entered a material agreement; Terminated a material agreement Feb 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Other events Feb 6, 2026 8-K Regulation FD disclosure Jan 14, 2026 8-K Director or officer change; Regulation FD disclosure Jan 9, 2026 8-K Other events Dec 18, 2025 8-K Shareholder vote results Dec 12, 2025 8-K Other events Dec 9, 2025 8-K Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Other events Oct 24, 2025 8-K Other events Oct 10, 2025 8-K Shareholder vote results; Other events Oct 1, 2025 8-K Other events Sep 8, 2025 8-K Other events Sep 2, 2025 8-K Other events Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Director or officer change Jul 14, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025